350 related articles for article (PubMed ID: 10683868)
1. Synthesis of new pyrido[4',3':4,5]thieno[2,3-d]-1,2,4-triazolo[3,4-c]pyrimidines and a 5,6-dihydro-1,2,4-triazolo[4",3":1',2']pyrido[4',3':4,5]thieno [2,3-d]-pyrimidine ring system.
Ahmed EK; Gohar AM; Ameen MA
Pharmazie; 2000 Jan; 55(1):31-4. PubMed ID: 10683868
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines.
Hafez HN; Abbas HA; El-Gazzar AR
Acta Pharm; 2008 Dec; 58(4):359-78. PubMed ID: 19103572
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of 7-methyl-5-oxo-1,5-dihydro-8-[1,2,4]-triazolo [4,3-c]pyrimidinecarboxylic acid derivatives.
Długosz A; Machoń Z; Jasztold-Howorko R
Pharmazie; 1989 Sep; 44(9):604-5. PubMed ID: 2608705
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimicrobial evaluation of naphtho[2,1-b]pyrano[2,3-d]pyrimidine and pyrano[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives.
Eid FA; Abd El-Wahab AH; Ali GA; Khafagy MM
Acta Pharm; 2004 Mar; 54(1):13-26. PubMed ID: 15050041
[TBL] [Abstract][Full Text] [Related]
9. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.
Lauria A; Patella C; Abbate I; Martorana A; Almerico AM
Eur J Med Chem; 2013 Jul; 65():381-8. PubMed ID: 23747807
[TBL] [Abstract][Full Text] [Related]
10. Preparation of 2,7-diaminosubstituted-[1,2,4]triazolo[1,5-a]pyrimidine-6-carbonitriles by solid-phase synthesis.
Cavallaro CL; Harikrishnan LS; Chi F; Dodd D; Purandare A
J Comb Chem; 2008; 10(1):28-30. PubMed ID: 17994705
[No Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of thieno [2',3':4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.
Ashour HM; Shaaban OG; Rizk OH; El-Ashmawy IM
Eur J Med Chem; 2013 Apr; 62():341-51. PubMed ID: 23376247
[TBL] [Abstract][Full Text] [Related]
12. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol.
Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM
Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents.
Ali KA; Ragab EA; Farghaly TA; Abdalla MM
Acta Pol Pharm; 2011; 68(2):237-47. PubMed ID: 21485297
[TBL] [Abstract][Full Text] [Related]
14. [A new synthesis method for pyrido[1,2-a]thieno[3,2-d]pyrimidine].
Briel D
Pharmazie; 2003 Nov; 58(11):836-7. PubMed ID: 14664343
[No Abstract] [Full Text] [Related]
15. Synthesis, isomerization, and antimicrobial evaluation of some pyrazolopyranotriazolopyrimidine derivatives.
Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
Arch Pharm (Weinheim); 2007 Jul; 340(7):345-51. PubMed ID: 17610300
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiallergy activity of 10-oxo-10H-pyrido[1,2-a]thieno[3,2-d]pyrimidines and 10-oxo-10H-pyrido[1,2-a]thieno[3,4-d]pyrimidines.
Connor DT; Sorenson RJ; Cetenko WA; Kerbleski JJ; Tinney FJ
J Med Chem; 1984 Apr; 27(4):528-30. PubMed ID: 6142956
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some new pyrimidine and fused pyrimidine derivatives (Part I).
Ahmed GA; el-Bahai S; Nasser ; Abd el-Salam M
Boll Chim Farm; 2003; 142(2):72-5. PubMed ID: 12705094
[TBL] [Abstract][Full Text] [Related]
18. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
19. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates.
Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL
Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between [1,2,4]triazolo[1,5-a] pyrimidine and [1,2,4]triazolo[4,3-a]-pyrimidine regioisomers by 1H-15N HMBC experiments.
Salgado A; Varela C; García Collazo AM; Pevarello P
Magn Reson Chem; 2010 Aug; 48(8):614-22. PubMed ID: 20589727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
